Skip to content

Prevention of Preterm Birth With a Pessary in Triplet

Status
Withdrawn
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02601443
Enrollment
0
Registered
2015-11-10
Start date
2015-11-30
Completion date
2019-12-31
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth

Brief summary

The incidence of multiple gestations has increased over the past years, mostly because of increased use of assisted reproductive technologies. Triplet pregnancies are at increased risk of preterm birth (PTB), which is the primary reason for their increased morbidity and mortality compared to singletons. Multiple gestations, including triplets, account for about 3% of all pregnancies in the US but constitute at least 10% of cases of PTB, over 30% of very low birth weight infants, and nearly 20% of infant mortality. A short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of PTB, including in multiple gestations. In singletons with a prior PTB and a short CL \<25mm before 24weeks, cerclage is associated with significant decreases in PTB and perinatal morbidity and mortality in the meta-analysis of randomized trials (RCTs). On the contrary, the effect of cerclage in multiple gesttations has been insufficiently studied, with meta-analysis data showing a possible harm from cerclage compared to controls. The aim of this RCT is to evaluate the efficacy of cervical pessary in prevention of PTB in unselected triplet gestations. We planned to assess outcomes in subgroup analysis of women with short cervical length (TVU CL \<30 mm)

Interventions

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 18-50 years of age * Triplet pregnancy (limits the participants to female gender) * Gestational age at randomization between 20(0) and 22(6)

Exclusion criteria

* Singleton, twin or higher order than triplets multiple gestation * Twin twin transfusion syndrome * Ruptured membranes * Lethal fetal structural anomaly * Fetal chromosomal abnormality * Cerclage in place (or planned placement) * Vaginal bleeding * Suspicion of chorioamnionitis * Ballooning of membranes outside the cervix into the vagina * Painful regular uterine contractions * Labor * Placenta previa

Design outcomes

Primary

MeasureTime frame
Preterm deliveryLess than 34 weeks gestation

Secondary

MeasureTime frameDescription
Preterm deliveryLess than 24, 28 and 37 weeks
Gestational age at deliveryTime of delivery
Birth weightTime of delivery
pontaneous preterm birth ratesLess than 24, 28, 34 and 37 weeks gestation
Spontaneous rupture of membranesLess than 34 weeks gestation
Intolerance to pessaryPrior to deliveryDefined as request for removal secondary to discomfort and/or discharge
Neonatal deathBetween birth and 28 days of age
Composite adverse neonatal outcomeBetween birth and 28 days of ageIncludes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis and neonatal death
Admission to neonatal intensive care unitBetween birth and 28 days of age
ChorioamnionitisTime of delivery
Significant adverse maternal effectsTime of deliveryIncludes heavy bleeding, injury (eg erosion; fistula; etc) to vagina; injury (eg erosion; fistula; etc) to bladder, cervical tear and uterine rupture
Type of delivery: rate of cesaran delivery, vaginal delivery and operative vaginal deliveryTime of delivery

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026